Page results
-
The oral and maxillofacial surgery department focuses on the delivery of care to patients with dento-alveolar needs.
-
Oral medicine is the non-surgical management of patients with diseases of the oral mucosal tissues (lining of the mouth).
-
Our pain clinics are patient-centred and evidence-based, encouraging patients to self-manage their persistent facial pain.
-
Professor Hough is a consultant heamatologist at UCLH. She has specialist expertise in the management of acute lymphoblastic leukaemia in teenagers and young adults, and the use of umbilical cord blood as an alternative source of haemopoietic stem cells.
-
Our non-emergency patient transport service is provided by G4S. G4S may use approved external sub-contractors to meet the demand of the service and/or the specific needs of our patients.
-
Professor Lunn's specialist clinical and research interests are in the inflammatory neuropathies, particularly Guillain-Barré syndrome, CIDP and paraproteinaemic neuropathies.
-
The tissue viability team is committed to providing support, training and education to clinical staff, patients and carers about maintaining, promoting skin integrity and preventing pressure sores.
-
The Oesophageal and stomach surgery service works very closely with the specialist Upper Gastrointestinal (GI) service, gastroenterology, nutrition, oncology and radiology departments at UCLH. It comprises UCLH-based and Barts Health-based surgeons.
-
The Charles Dent Metabolic Unit (CDMU) is one of the largest and longest established services in the world for the treatment of adolescents and adults (aged 16 years and older) with inherited metabolic diseases.
-
A safeguarding clinic dedicated to the long term needs of children and young people who have problems related to Sexual, gynaecological or genito-urinary health, Complex maltreatment including sexual abuse, female genital mutilation, factitious illness and related issues. We also see unaccompanied children, refugees and looked after children.
File results
-
FOI/2024/0327 - Treatment of non-UK nationals
-
FOI/2024/0329 - Metastatic renal cell carcinoma patients/ classification
-
FOI/2024/0464 - Theatre sessions/ productivity
-
FOI/2024/0467 - Drug Patient Level Contract Monitoring (DrPLCM) and SACT Cancer reports
-
FOI/2024/0333 - Elective treatment wait over 65 weeks
-
FOI/2024/0337 - IVF clinical unit/ embryology laboratory
-
FOI/2024/0338 - Ophthalmology outpatient activity 2022, 2023 and 2024
-
FOI/2024/0339 - PACS, VNA, RIS, digital pathology and cardiology PACS systems
-
FOI/2024/0341 - Robotic Process Automation (RPA)/ Intelligent Automation (IA) technology at Trust
-
FOI/2024/0344 - Cancer diagnosis following A&E attendance 2018-2023